BNP Paribas Asset Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-205
Closed -$5K 2265
2025
Q3
$5K Buy
205
+78
+61% +$2.95K ﹤0.01% 1809
2025
Q2
$7K Buy
+127
New +$10.2K ﹤0.01% 1871

Other funds holding AGL

BNP Paribas Asset Management's AGL Position: Q4 2025 in Review

BNP Paribas Asset Management sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 205 shares — an estimated $5K sold.

BNP Paribas Asset Management first reported a position in AGL in Q2 2025 and held it in 2 quarters. The position peaked at $7K in Q2 2025. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • BNP Paribas Asset Management reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • BNP Paribas Asset Management sold 205 Agilon Health shares in Q4 2025, an estimated $5K.
  • BNP Paribas Asset Management first reported a position in Agilon Health in Q2 2025 and held it in 2 quarters.
  • BNP Paribas Asset Management's Agilon Health position peaked at $7K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on BNP Paribas Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.